A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Blueprint Medicines Corporation
Assistance Publique - Hôpitaux de Paris
Imagine Institute
Cogent Biosciences, Inc.
Blueprint Medicines Corporation
Hospital Italiano de Buenos Aires
KU Leuven
M.D. Anderson Cancer Center
Blueprint Medicines Corporation
Assistance Publique - Hôpitaux de Paris
National Institute of Allergy and Infectious Diseases (NIAID)
Cogent Biosciences, Inc.
LEO Pharma
University Health Network, Toronto
University of Zurich
Medical University of Lublin
University Hospital, Toulouse
Foundation For Rare Disease Research
University Hospital, Toulouse
AB Science
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
University Hospital, Toulouse
Blueprint Medicines Corporation
University Hospital, Toulouse
Hong Kong Sanatorium & Hospital
National Institutes of Health Clinical Center (CC)
AB Science
National Institutes of Health Clinical Center (CC)
Meir Medical Center
Allakos Inc.
AB Science
AB Science
Medical University of Graz
National Institutes of Health Clinical Center (CC)
Novartis
University of Michigan
Charite University, Berlin, Germany
Patara Pharma
Hospital Virgen de la Salud
Hospital Virgen de la Salud
University of Zurich
University Medical Center Groningen
Medical College of Wisconsin
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)